dc.contributor.author | Lake, MA. University of Cambridge, Cambridge | |
dc.date.accessioned | 2020-03-20T18:06:59Z | |
dc.date.available | 2020-03-20T18:06:59Z | |
dc.date.issued | 2020-03-18 | |
dc.identifier.uri | https://www.rcpjournals.org/content/clinmedicine/20/2/124 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12663/494 | |
dc.description.abstract | In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market. Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak. The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan. Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics. This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features. | en_US |
dc.language.iso | English | |
dc.title | What we know so far: COVID-19 current clinical knowledge and research | en_US |
eihealth.country | England | en_US |
eihealth.category | Clinical characterization and management | en_US |
eihealth.type | Published Article | en_US |
eihealth.maincategory | Save Lives / Salvar Vidas | en_US |
dc.relation.ispartofjournal | Clinical Medicine Journal | |